United States · FDA National Drug Code directory
Meropenem
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51810-502_787e8e01-2098-46ef-838c-1f7170c37630
- Product NDC
- 51810-502
- Form
- INJECTION
- Composition / generic term
- Meropenem
- Labeler
- Qilu Antibiotics Pharmaceutical Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241230
- Source listing expiry
- 20261231
Source-listed ingredients
- MEROPENEM — 500 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (51810-502-02) / 20 mL in 1 VIAL (51810-502-01) · 51810-502-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →